Experts solve mystery of ancient ‘mummified dragon' discovered by Japanese shogun
Researchers believe they've cracked the mystery of a mummified 'rainbow dragon' that's been sitting in a Japanese treasure house for centuries.
The 'dragon' has been stashed at the Shosoin Treasure House in the historic Japanese city of Nara, according to Pen News.
The remains were reportedly found by Yoshinori Ashikaga, a 15th-century shogun, in 1429.
Legend states that Ashikaga cut a piece from the Ranjatai, a rare and valuable piece of agarwood, at the time of the skeleton's discovery.
The shogun was visiting the Todai-ji temple in Nara at the time.
Shortly after, a monk at the temple claimed to have seen 'something in the shape of a small dragon' that was dried by the sun. Ashikaga took the skeleton and preserved it.
4 The remains were reportedly found by Yoshinori Ashikaga, a 15th-century shogun, in 1429.
Office of the Shosoin Treasure House
4 Researchers used X-ray technology and radiocarbon dating to date the marten back to the 11th or 12th centuries.
Office of the Shosoin Treasure House
But was the skeleton a dragon after all? Researchers say not quite.
A recently published study said the 'dragon' was actually a female Japanese marten.
The fluffy, weasel-like animal is native to central and southern Japan.
'The two premolars are clearly visible, and this characteristic indicates that it is a species of the Martes genus,' the study states.
4 The skeleton was found at the Todai-ji temple in Nara in 1429.
Getty Images
Using x-ray technology and radiocarbon dating, researchers found that the marten dated back to the 11th or 12th centuries.
The Todai-ji temple underwent heavy renovations at the time, according to Pen News.
Experts believe the animal entered the building and was trapped before it died and was mummified.
Pictures show the marten missing its forelegs, making it resemble a dragon.
4 Experts believe the animal entered the building and was trapped before it died and was mummified.
Office of the Shosoin Treasure House
Legend states that rain would descend upon the treasure house every time the skeleton's repository was opened – and during the study, researchers fought heavy downpours that made traveling from Tokyo to Nara difficult.
Mami Tsuru, a conservationist at the Shosoin Treasure House, told Pen News she's certain the skeleton is the same one recorded by the Todai-ji monk.
'The age determination has significantly increased the possibility that the mummy is the sun-dried dragon-looking object recorded in the document from the Muromachi Period,' the expert said.
Tsuru added, 'We believe this is a good example of how Shosoin has protected not only beautiful items, but also all the items inside the repository.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Post
21 hours ago
- New York Post
Trump says he's withdrawing nomination of Musk associate Jared Isaacman to lead NASA
President Donald Trump announced late Saturday that he is withdrawing the nomination of tech billionaire Jared Isaacman, an associate of Trump adviser Elon Musk, to lead NASA, saying he reached the decision after a 'thorough review' of Isaacman's 'prior associations.' It was unclear what Trump meant and the White House did not immediately respond to an emailed request for an explanation. 'After a thorough review of prior associations, I am hereby withdrawing the nomination of Jared Isaacman to head NASA,' Trump wrote on his social media site. 'I will soon announce a new Nominee who will be Mission aligned, and put America First in Space.' 3 Jared Isaacman is no longer in the running to lead NASA. The Washington Post via Getty Images 3 Jared Isaacman was the first private citizen to conduct a spacewalk. AFP via Getty Images Trump announced in December during the presidential transition that he had chosen Isaacman to be the space agency's next administrator. Isaacman, 42, has been a close collaborator with Musk ever since buying his first chartered flight on Musk's SpaceX company in 2021. He is the CEO and founder of Shift4, a credit card processing company. He also bought a series of spaceflights from SpaceX and conducted the first private spacewalk. SpaceX has extensive contracts with NASA. The Senate Commerce, Science and Transportation Committee approved Isaacman's nomination in late April and a vote by the full Senate was expected soon. 3 President Trump announced plans to withdraw Isaacman's nomination after a 'thorough review' of his 'prior associations.' AP Musk appeared to lament Trump's decision after the news broke earlier Saturday, posting on the X site that, 'It is rare to find someone so competent and good-hearted.' SpaceX is owned by Musk, a Trump campaign contributor and adviser who announced this week that he is leaving the government after several months at the helm of the Department of Government Efficiency, or DOGE. Trump created the agency to slash the size of government and put Musk in charge. Semafor was first to report that the White House had decided to pull Isaacman's nomination.
a day ago
Trump admin live updates: White House drops NASA nominee with Musk ties
The senate was slated to vote on Jared Isaacman next week. 3:08 President Donald Trump on Friday claimed China violated its trade agreement with the U.S. and Treasury Secretary Scott Bessent said talks between the world's two largest economies stalled. This week, Trump's global tariff policy hit a major roadblock as two federal courts ruled he does not have the power to unilaterally impose some levies. The tariffs can stay in place, for now, as the court considers the administration's appeal. Meanwhile, Elon Musk is leaving his role as a "special government employee" but is expected to remain an unofficial adviser to Trump. Latest headlines: May 31, 2025, 4:24 PM EDT White House pulls NASA nominee Jared Isaacman, billionaire with Musk ties May 30, 2025, 8:11 PM EDT Trump touts US Steel-Nippon deal May 30, 2025, 6:13 PM EDT Trump says he's doubling tariffs on steel imports to 50% May 30, 2025, 2:42 PM EDT Trump on possible pardon for Diddy: 'I would certainly look at the facts' Here's how the news is developing. May 31, 2025, 4:24 PM EDT White House pulls NASA nominee Jared Isaacman, billionaire with Musk ties The White House withdrew Saturday the nomination of Jared Isaacman to become the next NASA administrator just days before his scheduled confirmation vote in the Senate. "It's essential that the next leader of NASA is in complete alignment with President Trump's America First agenda and a replacement will be announced directly by President Trump soon," Liz Huston, a spokesperson for the White House said in a statement. Isaacman, who is the CEO of the payment processing company Shift4, has had a long history with Musk and worked with SpaceX on commercial flights into space. Isaacman attempted to distance himself from Musk during his confirmation hearing as he was getting grilled by Democrats on the committee. Musk and Trump have emphasized their desire to prioritize Mars, whereas Isaacman clarified during questioning that a lunar landing would take precedence over a Mars mission. In a post on social media, Trump confirmed he had pulled the nomination. "After a thorough review of prior associations, I am hereby withdrawing the nomination of Jared Isaacman to head NASA," Trump said without elaborating. "I will soon announce a new Nominee who will be Mission aligned, and put America First in Space." May 30, 2025, 8:11 PM EDT Trump touts US Steel-Nippon deal President Donald Trump on Friday touted a "blockbuster agreement" between U.S. Steel and Japanese company Nippon Steel that he said would keep the iconic U.S. steelmaker in Pittsburgh -- though he previously opposed such a merger and offered few details on the intricacies of the deal. Trump discussed the deal during a rally at the Irvin Works plant in Allegheny County on Friday evening. President Donald Trump said he will double the tariff imposed on imports of steel from 25% to 50%. Trump made the announcement during a rally in Pennsylvania on Friday to discuss the "partnership" between U.S. Steel and Japan-based Nippon Steel. Trump said the increase in steel tariffs "will even further secure the steel industry in the United States." Trump imposed the 25% tariffs on steel and aluminum in March, about a month before he announced sweeping across-the-board tariffs on what he called " Liberation Day." In a follow-up post on social media, Trump said the increased rate would go into effect June 4. May 30, 2025, 2:51 PM EDT Musk says his child punched him in the face Elon Musk, wearing all black, had a visible bruise over his right eye while speaking at the Oval Office. Asked what happened, Musk said his 5-year-old son punched him in the face. "I said, 'Go ahead, punch me in the face.' And, he did," Musk said.
New York Post
3 days ago
- New York Post
Groundbreaking new treatment for aggressive breast cancer has 100% survival rate
Hope is on the horizon for patients with aggressive, inherited breast cancers. A recent clinical trial, led by researchers at Cambridge University, explored the effects of combining chemotherapy with the targeted cancer drug olaparib before surgery. Every patient who received this protocol survived the critical three-year post-treatment period. Advertisement 3 BRCA cancers are notoriously aggressive and difficult to treat. Vasyl – The research, published in Nature Communications, suggests this preemptive, two-part approach could be the most effective plan of treatment for early-stage breast cancer linked to BRCA1 and BRCA2 gene mutations. Breast cancer or BRCA genes are present in every cell of the human body. When functioning, BRCA1 and BRCA2 repair DNA and prevent cancerous changes. However, when a mutation compromises these genes, cancer risk increases. Inheriting this damaged DNA can increase the risk for breast and ovarian cancer in women and breast and prostate cancer in men. Advertisement BRCA1 or BRCA2 genes are more common in young women, and these mutations increase cancer risk by as much as 84%. Six percent of all breast cancer patients carry BRCA gene mutations, but in patients under 45, roughly 12% carry the gene. BRCA cancers are notoriously aggressive and difficult to treat. In 2013, Angelina Jolie, who carries the faulty BRCA1 gene, made headlines when she underwent a preventative double mastectomy. As a result of the procedure, Jolie, who lost her own mother to breast cancer, saw her chances of developing breast cancer drop from 87 percent to less than 5 percent. Advertisement The current protocol for treating BRCA cancers includes shrinking the tumour using chemotherapy and immunotherapy, before removing it through surgery. 3 Angelina Jolie, who carries the faulty BRCA1 gene, underwent a preventative double mastectomy. Getty Images The first three years after surgery — when there is the greatest risk of relapse or death — are critical. The trial recruited patients from across the UK and aimed to test the efficacy of combining chemotherapy with olaparib before surgery and carefully timing when these treatments were administered. Advertisement 'It is rare to have a 100% survival rate in a study like this and for these aggressive types of cancer.' Professor Jean Abraham The study revealed that allowing a 48-hour 'gap' between chemotherapy and olaparib treatments led to more positive outcomes. Researchers believe this interval allows the patient's bone marrow to recover from chemo while leaving tumor cells receptive to olaparib. Olaparib, sold under the brand name Lynparza, is typically taken for 12 months post-surgery. However, trial patients took the tablets pre-surgery for a period of 12 weeks. The survival rate among the control group who received chemotherapy alone was 88%. Of these 45 patients, nine relapsed and six died within three years of surgery. In contrast, there was a 100% survival rate among the 39 patients who received chemotherapy followed by olaparib. Of this cohort, only one patient relapsed in the three years following surgery. 'It is rare to have a 100% survival rate in a study like this and for these aggressive types of cancer,' said trial lead Professor Jean Abraham. 3 Olaparib, sold under the brand name Lynparza, is typically taken for 12 months post-surgery. However, trial patients took the tablets pre-surgery for a period of 12 weeks. AstraZeneca Pharmaceuticals Advertisement 'We're incredibly excited about the potential of this new approach, as it's crucial that we find a way to treat and hopefully cure patients who are diagnosed with BRCA1 and BRCA2-related cancers.' Compared to current care protocols, the two-pronged approach of chemo and olaparib pre-surgery offers a more cost-effective and less toxic treatment for patients. Abrahams and his team are planning the next research phase, which will aim to replicate their results in a larger study. Advertisement They are hopeful their findings can and will be applied to treat other cancers caused by mutated BRCA genes, including some ovarian, prostate, and pancreatic cancers. Breast cancer is the most common cancer among US women after skin cancer. About 1 in 8 women will be diagnosed with breast cancer in their lifetime. Though breast cancer starts in a localized part of the breast tissue, it can spread to other areas of the body, significantly decreasing rates of survival. Survival rates among breast cancer patients whose cancer is detected before it spreads are high, between 86% and 89%. Yet if the cancer is detected after the cancer cells have migrated, that number drops to 31%.
